Mitochondrial dysfunction in metabolic and cardiovascular diseases associated with cardiolipin remodeling

Biochim Biophys Acta Mol Basis Dis. 2020 Jun 1;1866(6):165744. doi: 10.1016/j.bbadis.2020.165744. Epub 2020 Feb 24.

Abstract

Cardiolipin (CL) is an acidic phospholipid almost exclusively found in the inner mitochondrial membrane, that not only stabilizes the structure and function of individual components of the mitochondrial electron transport chain, but regulates relevant mitochondrial processes, like mitochondrial dynamics and cristae structure maintenance among others. Alterations in CL due to peroxidation, correlates with loss of such mitochondrial activities and disease progression. In this review it is recapitulated the current state of knowledge of the role of cardiolipin remodeling associated with mitochondrial dysfunction in metabolic and cardiovascular diseases.

Keywords: Cardiolipin; Metabolic diseases; Mitochondrial function.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Apoptosis / genetics
  • Cardiolipins / genetics*
  • Cardiovascular Diseases / genetics*
  • Cardiovascular Diseases / metabolism
  • Cardiovascular Diseases / pathology
  • Energy Metabolism / genetics
  • Humans
  • Lipid Peroxidation / genetics
  • Mitochondria / genetics*
  • Mitochondria / pathology
  • Mitochondrial Dynamics / genetics
  • Mitochondrial Membranes / metabolism
  • Oxidative Stress / genetics*

Substances

  • Cardiolipins